What Ejection Fraction Measures and Where It Falls Short

Ejection fraction is a ratio: the share of blood the left ventricle pushes out with each beat, expressed as a percentage. It is easy to picture, cheap to obtain, and deeply embedded in guidelines, yet it is a blunt instrument. A single ejection fraction number carries real measurement error, shifts with blood pressure and hydration, and stays normal until a surprising amount of heart muscle has already weakened. Understanding what the number captures, and what it misses, is the difference between reading a result and over-reading it.

What ejection fraction actually measures

The left ventricle fills with blood between beats (end-diastolic volume) and ejects a portion of it during each contraction. The stroke volume divided by the end-diastolic volume, times 100, is the ejection fraction. If the ventricle holds 120 milliliters and ejects 66, the ejection fraction is roughly 55 percent. A normal heart does not empty completely; ejecting a little over half its contents per beat is expected.

On an echocardiogram, the number is usually estimated with the Simpson biplane method, which traces the inner border of the ventricle in two views, models it as a stack of thin discs, and sums their volumes at end-diastole and end-systole. According to the 2015 chamber-quantification recommendations from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, the normal range sits at roughly 52 to 72 percent in men and 54 to 74 percent in women. Values below those lower limits define reduced systolic function.

That reference range does real work. It sorts heart failure into categories, gates eligibility for devices such as implantable defibrillators, and triggers decisions to pause potentially cardiotoxic cancer drugs. Because so much rides on which side of a threshold a patient lands, the precision of the measurement matters as much as the biology it represents.

Where the number falls short

Measurement variability

The first problem is reproducibility. The Simpson method depends on how clearly the endocardial border is seen and how consistently a sonographer traces it, and different observers trace it differently. A 2013 study in the Journal of the American College of Cardiology by Thavendiranathan and colleagues, focused on women undergoing chemotherapy for breast cancer, quantified this. On repeated two-dimensional echocardiography, the temporal variability in ejection fraction could exceed 10 percentage points, while three-dimensional echocardiography narrowed it to about 6. In practical terms, a fall from 60 to 52 percent between two scans can be entirely measurement noise rather than a true change in the heart.

That is not a small caveat. It is precisely why guidelines that use ejection fraction to define cancer-therapy cardiac dysfunction call for confirming a drop on a repeat study rather than acting on a single reading, and why they favor the same equipment and reader over time.

Load dependence

The second problem is physiologic. Ejection fraction is a ratio of volumes, so anything that changes filling or the resistance the ventricle pumps against changes the number, even when the muscle itself is unchanged. High blood pressure raises afterload and can lower the measured fraction; a dehydrated patient with low filling volumes can post a reassuringly high one. This load dependence means a single value describes the loading conditions at the moment of the scan as much as it describes contractility. Two readings weeks apart can differ because the patient's blood pressure or fluid status differed, not because the heart got better or worse.

Late sensitivity

The third problem is timing. Ejection fraction is a global average that tends to stay within the normal range until dysfunction is fairly advanced, partly because the heart compensates. As some muscle weakens, remaining segments can contract harder and geometry can shift to preserve the overall ratio. By the time the fraction visibly falls, meaningful injury may already have occurred. For patients on cardiotoxic chemotherapy, waiting for the number to drop can mean waiting past the window where earlier intervention would have helped.

Why strain imaging entered the picture

Global longitudinal strain addresses several of these gaps at once. Rather than estimating a volume ratio, speckle-tracking echocardiography follows the motion of tiny acoustic markers in the muscle across the cardiac cycle and reports how much the myocardium shortens along its long axis, as a negative percentage. A more negative value, in the range of about minus 18 to minus 20 percent on many systems, reflects better shortening; a less negative value signals weaker deformation.

Two features make strain attractive. First, it measures deformation directly instead of relying on the geometric assumption that the ventricle is a tidy symmetric shape, an assumption that breaks down after a heart attack or wherever contraction is regional. The 2019 study by Karlsen and colleagues in Cardiovascular Ultrasound, a dedicated reproducibility analysis, found global longitudinal strain more reproducible than ejection fraction, reporting an intraclass correlation coefficient of about 0.89 for strain versus roughly 0.63 for ejection fraction, and noting that the advantage held regardless of the reader's level of echocardiographic training.

Second, strain tends to fall before ejection fraction does. Because it captures subtle, regional shortening deficits that a global ratio can mask, a relative drop of more than 15 percent from a patient's own baseline is the threshold many cardio-oncology protocols use to flag subclinical dysfunction. The 2022 European Society of Cardiology cardio-oncology guideline incorporates strain alongside ejection fraction and biomarkers for exactly this reason. The randomized SUCCOUR trial tested the idea directly: managing chemotherapy patients by strain rather than ejection fraction led to markedly more use of cardioprotective medication, though at three years the average ejection fraction was similar in the two groups. The trial shows that acting on the earlier signal changes management; how much that alters long-term outcomes is still being studied.

How to read an ejection fraction sensibly

None of this makes ejection fraction obsolete. It remains the anchor for classifying heart failure and for most treatment guidelines, and strain has its own limits, including meaningful variation between vendor software packages that keeps universal cutoffs contentious. The point is interpretive humility. A single ejection fraction is an estimate with a margin of error of several percentage points, measured under specific loading conditions, that can stay normal while trouble is building. Read as a trend on consistent equipment, alongside strain and clinical context, it is genuinely useful. Read as a precise, standalone verdict, it promises more certainty than the measurement can deliver.

This article is educational and is not medical advice; decisions about cardiac testing and treatment belong with a qualified clinician who knows the individual case.